<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated 40 consecutive carotid endarterectomy specimens for the presence of fibrin </plain></SENT>
<SENT sid="1" pm="."><plain>Intraplaque <z:mp ids='MP_0001914'>hemorrhage</z:mp> was noted in 93% of specimens </plain></SENT>
<SENT sid="2" pm="."><plain>At the plaque surface, there were two patterns of fibrin distribution </plain></SENT>
<SENT sid="3" pm="."><plain>Type I, suggesting a lumen <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e>, was found in 7 specimens </plain></SENT>
<SENT sid="4" pm="."><plain>Type II, suggesting an intraplaque <z:mp ids='MP_0001914'>hemorrhage</z:mp> at the lumen surface, was found in 15 specimens </plain></SENT>
<SENT sid="5" pm="."><plain>These changes were not significantly associated with the presence of ischemic symptoms or the use of antiplatelet or <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> medications </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> specimens with Type I change had arteriographic evidence of at least 70% diameter stenosis </plain></SENT>
<SENT sid="7" pm="."><plain>The frequent lack of fibrin at the plaque surface suggests that there may be inherent limitations of standard medical treatment for <z:e sem="disease" ids="C0007273" disease_type="Disease or Syndrome" abbrv="">carotid artery disease</z:e> </plain></SENT>
</text></document>